The FDA is adding a warning label on diabetes pen devices, making clear that the pens are intended for single patient use only and shouldn’t be shared, even if the needle is changed.
In an announcement on their website last week, the agency said they are trying to reduce the risk of serious infections from the sharing of multidose pens. They will require that pens and packaging with multiple doses of insulin or other injectable diabetes medicines carry a warning label stating “For single patient use only.”
